Evaluation of an Interventional Module to Assist Physicians Introducing ACP to Cancer Patients

NCT ID: NCT04969952

Last Updated: 2024-06-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

384 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-06

Study Completion Date

2023-12-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of an Interventional module to assist physicians introducing ACP to cancer patients

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Investigators hypothesize that compared to ACP brochure alone, educational module plus ACP brochure is effective in assisting the physicians to introduce ACP to the patients and completion of AD documentation

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Shared decision making (SDM) process through Advance Care Planning (ACP) consultation with cancer patients
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Caregivers
Only investigator know

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Group A had watching educational module plus ACP brochure

Group Type EXPERIMENTAL

For interventional module

Intervention Type OTHER

Using vedio to assist physicians introducing advance care planning to cancer patients

Group B

Group B ACP brochure only

Group Type ACTIVE_COMPARATOR

For interventional module

Intervention Type OTHER

Using vedio to assist physicians introducing advance care planning to cancer patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

For interventional module

Using vedio to assist physicians introducing advance care planning to cancer patients

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Older than 20-years-old
2. Diagnosed with cancer
3. Have not signed any form of AD or DNR

Exclusion Criteria

1. Under 20-years-old
2. Can not speak or listen, difficult communication
3. Signed AD or DNR
Minimum Eligible Age

20 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Taiwan University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shao-Yi Cheng Shao-Yi, PHD

Role: PRINCIPAL_INVESTIGATOR

Shao-Yi Cheng

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nation Taiwan University Hospital

Taipei, , Taiwan

Site Status

National Taiwan University Hospital

Taipei County, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

201912238RINA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.